Menu
GeneBe

15-99729449-C-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001284417.2(LYSMD4):ā€‹c.565G>Cā€‹(p.Glu189Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000545 in 1,614,188 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00043 ( 0 hom., cov: 33)
Exomes š‘“: 0.00056 ( 9 hom. )

Consequence

LYSMD4
NM_001284417.2 missense

Scores

1
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.942
Variant links:
Genes affected
LYSMD4 (HGNC:26571): (LysM domain containing 4) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037824273).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000558 (815/1461846) while in subpopulation MID AF= 0.0224 (129/5768). AF 95% confidence interval is 0.0192. There are 9 homozygotes in gnomad4_exome. There are 429 alleles in male gnomad4_exome subpopulation. Median coverage is 77. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LYSMD4NM_001284417.2 linkuse as main transcriptc.565G>C p.Glu189Gln missense_variant 3/3 ENST00000684762.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LYSMD4ENST00000684762.1 linkuse as main transcriptc.565G>C p.Glu189Gln missense_variant 3/3 NM_001284417.2 P1Q5XG99-1

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000628
AC:
158
AN:
251420
Hom.:
1
AF XY:
0.000743
AC XY:
101
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000784
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000686
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.000558
AC:
815
AN:
1461846
Hom.:
9
Cov.:
77
AF XY:
0.000590
AC XY:
429
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.00108
Gnomad4 AMR exome
AF:
0.00121
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000974
Gnomad4 FIN exome
AF:
0.0000375
Gnomad4 NFE exome
AF:
0.000404
Gnomad4 OTH exome
AF:
0.00101
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152342
Hom.:
0
Cov.:
33
AF XY:
0.000430
AC XY:
32
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.000718
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000830
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000573
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000653
Hom.:
1
Bravo
AF:
0.000412
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000544
AC:
66
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 23, 2021The c.568G>C (p.E190Q) alteration is located in exon 6 (coding exon 4) of the LYSMD4 gene. This alteration results from a G to C substitution at nucleotide position 568, causing the glutamic acid (E) at amino acid position 190 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
12
DANN
Uncertain
0.98
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.70
T;T;T;T
M_CAP
Benign
0.0052
T
MetaRNN
Benign
0.038
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationTaster
Benign
0.93
D;D;D;N
PrimateAI
Benign
0.28
T
REVEL
Benign
0.11
Sift4G
Benign
0.090
T;T;T;T
Polyphen
0.33, 0.79
.;.;B;P
Vest4
0.055
MVP
0.29
MPC
0.32
ClinPred
0.026
T
GERP RS
4.2
Varity_R
0.12
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200602575; hg19: chr15-100269654; API